Skip to content
Screener

Medtronic MDT Total Revenue

Total Revenue at other companies

Abbott logo
AbbottABT
$12.59B+13.0%
TFX
TeleflexTFX
$570.33M+28.9%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$25.31B+6.6%
Stryker logo
StrykerSYK
$6.59B+9.4%
CONMED logo
CONMEDCNMD
$343.49M+0.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$381.88M+7.5%

Segments

By segment

See full
Cardiovascular$3.93B+19.5%
Neuroscience$2.68B+10.3%
Medical Surgical$2.28B+9.9%
Diabetes$843M+16.9%
Other operating segment, misc$29M—

By geography

See full
UNITED STATES$4.24B—
Ireland$28M—

Other financials

Income statement

See full
Gross profit$6.3B+13.7%
Operating income$1.8B+22.1%
Net income$1.5B+41.3%
EPS (diluted)$1.14+40.7%

Balance sheet

See full
Cash & equivalents$1.7B+32.8%
Total debt$28.2B-1.6%
Total equity$50.2B+4.9%
Total assets$93.3B+2.6%

Cash flow

See full
Operating cash flow$1.8B+64.8%
CapEx$503.0M-0.2%
Free cash flow$1.3B+121%

Valuation

See full
Market cap$112.24B-9.3%
Enterprise value$138.76B-8.2%
P/E21.5×-5.1×
P/S3×-0.6×

Profitability

See full
Gross margin65%-0.3pp
Operating margin18.1%+0.2pp
Net margin13.9%+0.3pp
FCF margin16.3%+0.8pp

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.6×0.0×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by Medtronic in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Medtronic’s 10-Q, filed September 3, 2026.

Filed
Sep 3, 2026, 4:18 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q3 2026
Accession
0001628280-26-060473
(in millions, except per share data)Three months ended / July 31, 2026Three months ended / July 25, 2025
Net sales$9,756$8,578
Costs and expenses:
Cost of products sold, excluding amortization of intangible assets3,4163,001
Research and development expense771726
Selling, general, and administrative expense3,1982,806
Amortization of intangible assets412459
Restructuring charges, net7245
Certain litigation charges, net—27

Item 1. Financial Statements

FAQ

What is Medtronic's total revenue?
Medtronic (MDT) reported total revenue of $9.76B in Q2 2026.
How has Medtronic's total revenue changed year-over-year?
Medtronic's total revenue increased by 13.7% year-over-year, from $8.58B to $9.76B.
What is the long-term trend for Medtronic's total revenue?
Over 4 years (2022 to 2026), Medtronic's total revenue has grown at a 3.5% compound annual growth rate (CAGR), from $31.69B to $36.36B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Medtronic's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude